Key: Blue: Discovery Company Presentations Purple: National Science Foundation Discovery Companies

Tuesday October 8, 2013

Marina

Pacific Heights

8:30 – 8:55am 9:00 – 9:25am 9:30 – 9:55am 10:00 – 10:25am 10:30 – 10:55am 11:00 – 11:25am 11:30 – 11:55am

Discovery Companies

Sialix Altravax Gemmus Pharma Leading Biosciences Numab AG viDA Therapeutics Recardio ScarX Therapeutics DiscoveryBioMed TheraVasc Vascular Pharmaceuticals

Viking Therapeutics SironRX Therapeutics Maverix Biomics Kala Pharmaceuticals

12:00 – 1:25pm

2:00 – 2:25pm 2:30 – 2:55pm 3:00 – 3:25pm 3:30 – 3:55pm 4:00 – 4:25pm 4:30 – 4:55pm

Twin Peaks North

Protagonist Therapeutics

Mirna Therapeutics

Inovio Pharmaceuticals

Spring Bank Pharmaceuticals

Zymeworks

Fate Therapeutics

CytomX Therapeutics

TBD

Catalyst Pharmaceutical

Bellicum Pharmaceuticals

Elusys Therapeutics

ZIOPHARM Oncology

Dicerna Pharmaceuticals

Theraclone Sciences

TBD

Aquinox Pharmacueticals

Regado Biosciences

La Jolla Pharmaceutical Co.

Opsona Therapeutics

ContraFect Corp

Bio-Path Holdings

EGEN

Innovus Pharma

A Guide to Effective Patient Foundation and Life Science Industry Collaborations By BayBio, featuring Foundation Presentations

Therapeutic Workshop The Ultimate Rejection: Fighting Cancer with Immunotherapy

Opening Plenary Lunch: IPO Frenzy - Are the GoGo Markets Here to Stay? [The Investor Perspective]

(Box Lunches)

1:30 – 1:55pm

Sea Cliff

Networking Breakfast (Sunset Court)

7:00 – 7:55am 8:00 – 8:25am

Presidio

Stemina Biomarker Discovery ADM Diagnostics CertiChem Nano3D Biosciences Nanofiber Solutions Tymora Analytical Operations Biodesy Carmot Therapeutics Parabon Nanolabs Jade Therapeutics PreScience Labs Confluence Life Sciences BEAT Biotherapeutics Visionary Pharmaceuticals

5:00 – 7:00pm Schedule as of October 7, 2013. Subject to change.

S1 Biopharma

GenSpera

TissueGene

MabVax Therapeutics

RXi Pharmaceuticals

Forma Therapeutics

OncoSec

Benitec Ltd

Hua Medicine

Zafgen

Mast Therapeutics

MaxCyte

CG Pharmaceuticals

Palatin Technologies

Vaccinex

OxiGENE

Ocera Therapeutics

Therapeutic Workshop GAINing Ground in Antibiotics: New Incentives for Biopharma

Business Roundtable Crowdfunding in Healthcare & Biotech: Will It Bridge the ‘Valley of Death’?

Conatus Pharmaceuticals

Reception (Garden Court) www.bio.org/investorforum

Wednesday October 9, 2013

Marina

Pacific Heights

9:00 – 9:25am 9:30 – 9:55am 10:00 – 10:25am 10:30 – 10:55am 11:00 – 11:25am 11:30 – 11:55am 12:00 – 12:25pm 12:30 – 1:25pm (Box Lunches)

Sea Cliff

Twin Peaks North

Networking Breakfast (Sunset Court)

7:30 – 8:25am 8:30 – 8:55am

Presidio

Max BioPharma GeneCentric Diagnostics Anthrocell Pty Ltd. Armour Therapeutics ImmunGene NewGen Therapeutics Sensorion Pharmaceuticals NovelMed Therapeutics Coyote Pharmacueticals EicOsis FPRT Bio America Stem Cell Clinical Persona Applied Integrin Sciences INanoBio Metactive Medical

Labrys Biologics

TherapeuticsMD

OncoMed Pharmaceuticals

Auspex Pharmaceuticals

Patrys Ltd.

Galena Biopharma

BioCrea

Polynoma LLC

Critical Outcome Technologies

Altheus Pharmaceuticals

Immune Pharmaceuticals

Horizon Pharma

AM-Pharma Holding

Blueprint Medicines

Neostem

Cell Medica

Proteon Therapeutics

TBD

OxThera AB

Ambrx

Resverlogix

Versartis

Neuraltus Pharmaceuticals

diaDexus

Therapeutic Workshop The Non-Orphan Panel: Shifting the Focus from Rare Diseases to Primary Care

Fireside Chat: Jan M. Lundberg, PhD, Executive Vice President, Science & Technology and President, Lilly Research Laboratories

Plenary Lunch: Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary

1:30 – 1:55pm

Vivaldi Biosciences

Eleison Pharmaceutical

Sernova Corp

Heat Biologics

2:00 – 2:25pm

Immune Design

Cerecor

International Stem Cell Corp

TBD

2:30 – 2:55pm

Probiodrug AG

Igenica

Sophiris Bio

Ambit Biosciences

3:00 – 3:25pm

Asuragen

Business Roundtable The New Road to IPO in the Age of the JOBS Act [The Company Perspective]

Lion Biotechnologies

3:30 – 4:25pm

Closing Plenary: Early Stage Venture Financing – Will Current Trends Continue in 2014?

4:30 – 5:30pm

Closing Happy Hour (Sunset Court)

Schedule as of October 7, 2013. Subject to change.

www.bio.org/investorforum